Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONS2-(1-Piperazinyl)pyrimidine is an antagonist of α2-adrenergic receptors (α2-ARs; pA2 = 6.8 in rat brain synaptosomes) and an active metabolite of various azapirones.1,2,3,4 It is an active metabolite of tandospirone (Item No. 40436), buspirone, ipsapirone (Item No. 39918 | 22075), and gepirone, among others. 2-(1-Piperazinyl)pyrimidine prevents clonidine-induced slowing of gastrointestinal transit in rats (ED50 = 0.8 mg/kg).2 It increases drinking in the Vogel punished drinking task, indicating anxiolytic-like activity, in rats when administered at doses ranging from 1 to 4 mg/kg.3 2-(1-Piperazinyl)pyrimidine (0.25-1 mg/kg) also reduces the amplitude of electrically stimulated excitatory post-synaptic potentials (EPSPs) in the hippocampal CA1 region in rats, an effect that can be blocked by the serotonin (5-HT) receptor subtype 5-HT1A antagonist spiroxatrine.4 It has also been used as a phosphopeptide derivatization agent.5
WARNING This product is not for human or veterinary use.
1. Antagonist properties of 1-
2. The α2-
3. α2-
4. The azapirone metabolite 1-
5. Carboxy group derivatization for enhanced electron-